1
Investors
About
Insmed Incorporated is a global biopharmaceutical company that develops and commercializes therapies for patients with serious and rare lung diseases, including pulmonary arterial hypertension and nontuberculous mycobacterial lung infections.
Explore Insmed Incorporated's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.